Does RISANKIZUMAB-RZAA Cause Cataract? 747 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 747 reports of Cataract have been filed in association with RISANKIZUMAB-RZAA. This represents 1.1% of all adverse event reports for RISANKIZUMAB-RZAA.
747
Reports of Cataract with RISANKIZUMAB-RZAA
1.1%
of all RISANKIZUMAB-RZAA reports
0
Deaths
37
Hospitalizations
How Dangerous Is Cataract From RISANKIZUMAB-RZAA?
Of the 747 reports, 37 (5.0%) required hospitalization.
Is Cataract Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 747 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Cataract?
ADALIMUMAB (3,157)
METHOTREXATE (1,785)
INSULIN LISPRO (1,676)
LENALIDOMIDE (1,658)
ETANERCEPT (1,451)
PREDNISONE (1,365)
RITUXIMAB (1,332)
INSULIN GLARGINE (1,313)
ABATACEPT (1,065)
TOFACITINIB (1,050)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Cataract Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA